Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Moriarty

Vascular & Interventional Radiology Los Angeles, CA Medical Doctor

NPI 1609009125 CMS profile 550978

100 Ucla Medical Plz Ste 100, Los Angeles, CA 90024

Open in the dashboard

General payments

$526,610

352 records reported · program years 2019–2025

Research payments

$128,990

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$191,953 paid to institutions, not to them · program years 2019–2025

Through program year 2025, John Moriarty of Los Angeles, CA is reported in the CMS Open Payments database as having received $526,610 across 352 general payments and $128,990 in research payments paid to them. Separately, studies naming them as principal investigator received $191,953 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $62,573 67
2024 General $101,312 70
2023 General $152,574 73
2023 Research $1,540 3
2022 General $97,674 62
2022 Research $350 2
2021 General $57,865 16
2021 Research $2,100 1
2020 General $25,309 10
2019 General $29,304 54
2019 Research $125,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Moriarty
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to John Moriarty were reported at $62,573. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year John Moriarty Vascular & Interventional Radiology median Middle half National median
2019 $29,304 $422 $125–$1,555 $163
2020 $25,309 $200 $68–$652 $114
2021 $57,865 $280 $99–$866 $132
2022 $97,674 $433 $137–$1,497 $149
2023 $152,574 $506 $152–$2,019 $160
2024 $101,312 $556 $175–$1,930 $164
2025 $62,573 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $305,618 94 payments
  2. Penumbra, Inc. $120,901 80 payments
  3. Siemens Medical Solutions USA, Inc. $20,599 38 payments
  4. Argon Medical Devices, Inc. $19,312 24 payments
  5. Imperative Care, INc $16,524 21 payments
  6. Inari Medical, Inc. $14,490 13 payments
  7. Boston Scientific Corporation $9,324 20 payments
  8. Stryker Corporation $7,056 5 payments
  9. Bard Peripheral Vascular, Inc. $3,286 7 payments
  10. Pfizer Inc. $2,000 2 payments
  11. Other $7,501 48 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $381,650 92 payments
  2. Travel and Lodging $64,349 81 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $58,746 22 payments
  4. Food and Beverage $16,981 151 payments
  5. Honoraria $3,524 5 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,360 1 payment
Products named General payments · program years 2019–2025
  1. ANGIOVAC Vit $152,388 45 payments
  2. Indigo System $110,925 69 payments
  3. AngioVac Endovascular Therapies $49,259 2 payments
  4. AURYON LASER SYSTEM 100-120 VAC $43,370 7 payments
  5. ALPHAVAC $38,745 30 payments
  6. CT THROMBECTOMY SYSTEM KIT $17,101 11 payments
  7. FLOWTRIEVER CATHETER, S $17,101 11 payments
  8. ZOOM 88-T LARGE DISTAL PLATFORM $15,709 8 payments
  9. Artis icono floor $11,099 16 payments
  10. CLEANER $7,041 14 payments
  11. Other $48,965 162 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AngioDynamics, Inc. $125,000 1 payment
  2. Medtronic, Inc. $2,538 4 payments
  3. Asahi Intecc USA, Inc. $1,452 2 payments

Billing to Medicare

Part B · data year 2024 · 118 billing codes

Paid by Medicare

$146,966

Of which drugs: $4,239

Medicare patients

487

Average age 72

Services billed

32,374

227 women, 260 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 53%
Diabetes 36%
Heart failure 32%
Chronic kidney disease 32%
Atrial fibrillation 28%
Osteoporosis 24%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 210 23,100 $2,444
Injection, gadobutrol, 0.1 ml A9585 Office 43 4,950 $1,195

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

359 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record